Sequence Similarity Clusters for the Entities in PDB 2NXZ

Entity #1 | Chains: A
ENVELOPE GLYCOPROTEIN GP120 protein, length: 317 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 4 4 22468
95 % 6 15 4669 Flexibility: Medium
Max RMSD: 16.1, Avg RMSD: 5.8
PDBFlex
90 % 6 15 4698
70 % 30 207 127
50 % 30 207 147
40 % 30 207 161
30 % 30 210 177
Entity #2 | Chains: B
T-cell surface glycoprotein CD4 protein, length: 184 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 8 40 873
95 % 8 46 828 Flexibility: Low
Max RMSD: 2.4, Avg RMSD: 1.2
PDBFlex
90 % 8 46 859
70 % 8 46 909
50 % 8 46 953
40 % 8 46 983
30 % 8 46 963
Entity #3 | Chains: C
ANTIBODY 17B, LIGHT CHAIN protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 6 22 1529
95 % 8 34 1144 Flexibility: Low
Max RMSD: 5.3, Avg RMSD: 1.2
PDBFlex
90 % 248 865 2
70 % 752 2765 1
50 % 1558 5625 1
40 % 1820 6382 1
30 % 2215 7934 1
Entity #4 | Chains: D
ANTIBODY 17B, HEAVY CHAIN protein, length: 229 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 6 26 1249
95 % 6 26 1490 Flexibility: Low
Max RMSD: 3.9, Avg RMSD: 1.0
PDBFlex
90 % 6 26 1511
70 % 750 2728 2
50 % 1559 5625 1
40 % 1821 6382 1
30 % 2216 7934 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
3 6MEE 2 B, D antibody HEPC74 Light Chain 9606
4 6BJZ 2 L 5c8 Fab Light chain 9606
5 4XCF 1 L 4E10 Fab light chain 9606
6 5X08 2 L Fab 4E10 Light chain 9606
7 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
8 4XAW 1 L 4E10 Fab light chain 9606
9 5UCB 2 L Fab Light Chain 9606
10 2VXV 2 L HUMAN IGG ABT-325 9606
11 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
12 5I8C 2 B VRC34.01 Fab light chain 9606
13 5WK2 1 L M116 LIGHT CHAIN 9606
14 3PP4 2 L GA101 Fab light chain 10090
15 4PTU 1 A Antibody pn132p2C05, light chain 9606
16 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
17 4XC3 1 L 4E10 Fab light chain 9606
18 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
19 5VSI 2 L CH1/Ckappa Fab light chain 9606
20 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
21 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
22 4NWU 2 L APE1551 Ab Fab light chain 9606
23 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
24 5EWI 2 L VRC38.01 Light Chain 9606
25 5E2W 1 L AT8 LIGHT CHAIN 10090
26 5E2V 1 L AT8 LIGHT CHAIN 10090
27 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
28 6CA7 1 L PCT64_13C light chain 9606
29 5OB5 3 L fAb Light chain 9606
30 3QQ9 1 C, L 101F LIGHT CHAIN 10090
31 5I1K 1 L FAB LIGHT CHAIN 9606
32 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
33 5V7U 1 L CBTAU-22.1 Fab light chain 9606
34 5UEA 3 B, L Fab Light Chain 9606
35 5NMV 1 L Fab light chain 10088
36 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
37 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
38 3QRG 1 L Fab light chain 9606
39 3NCJ 1 L Fab15 Mut8 light chain 9606
40 5W05 1 L M59 FAB LIGHT CHAIN 10090
41 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
42 1UM5 1 L Antibody 21H3 L chain 10090
43 4NWT 1 L APE1531 Ab Fab light chain 9606
44 3NA9 1 L Fab15 light chain 9606
45 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
46 4LRI 1 A, B MSL-109 Light Chain 9606
47 4JN2 1 A, L anti dabigatran Fab 10090
48 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
49 5U6A 1 A Light Chain 9606
50 4HHA 1 A Fab KE5 Fab fragment KE5 9606
51 5UEK 3 L Fab 12E Light Chain 9606
52 3NAA 1 L Fab15 Mut5 light chain 9606
53 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
54 5IK3 2 B, D 1E03 Fab fragment light chain 9606
55 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
56 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
57 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
58 5IT2 2 L light chain 9606
59 6DW2 1 A 6078 Fab light chain 9606
60 6BQB 1 L MGG4 Fab light chain 9606
61 4PUB 2 L DX-2930 LIGHT CHAIN 9606
62 6B14 2 L Light chain of Fab BL3-6S97N 10090
63 5VKD 3 L Fab light chain 9606
64 5XHG 1 A, C polypeptide(L) 10090
65 3OAZ 2 K, L Fab 2G12, light chain 9606
66 4YGV 2 B, L aDabi-Fab2a light chain 9606
67 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
68 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
69 3EO0 1 A, C GC-1008 Fab Light Chain 10090
70 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
71 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
72 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
73 4JHA 2 L D25 light chain 9606
74 6B9Z 1 A Trastuzumab Fab light chain 10090
75 4PTT 1 A Antibody pn132p2C05, light chain 9606
76 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
77 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
78 4DGV 2 L HCV1 Light Chain 9606
79 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
80 3IU4 2 L chP3 Fab light chain 10090
81 3P0Y 3 L Fab DL11 light chain 9606
82 6ANA 3 L LL2 Fab Light Chain 10090
83 5IBU 1 B, L 6652 Light Chain 9606
84 6AOD 1 A FXIa Antibody FAB Light Chain 9606
85 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
86 6ELE 2 B, L fAB light chain 9606
87 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
88 3NAC 1 L Fab15 Mut7 light chain 9606
89 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
90 4YHO 2 L aDabi-Fab3 light chain 9606
91 4DGY 2 L HCV1 Light Chain 9606
92 3MXW 2 L 5E1 light chain 9606
93 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
94 3EO9 1 L Efalizumab Fab fragment, light chain 9606
95 6N35 1 K, L Fab 2G12 light chain 9606
96 5WUV 1 L light chain 9606
97 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
98 6B0G 1 C 1245 Antibody, Light Chain 9606
99 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
100 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
101 6D0X 2 B 1210 Antibody, light chain 9606
102 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
103 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
104 5TL5 1 L M2177 LIGHT CHAIN 10090
105 2FX7 1 L Fab 4E10 Light Chain 9606
106 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
107 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
108 5XKU 2 B HNIgGA6 light chain 9606
109 5I18 1 L FAB LIGHT CHAIN 9606
110 4JN1 2 L anti-dabigatran Fab1, light chain 10090
111 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
112 3SOB 1 L antibody light chain 9606
113 6B5M 2 L CIS43 Fab Light chain 9606
114 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
115 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
116 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
117 5DR5 2 L AbD09097 Fab light chain 9606
118 4KQ3 1 L CNTO3186 light chain Fab 9606
119 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
120 4I77 2 L Lebrikizumab light chain Fab 9606
121 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
122 4HJG 1 A Trastuzumab light chain 9606
123 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
124 3FN0 1 L Fab Z13e1 light chain 9606
125 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
126 4YHI 2 B, L aDabi-Fab2a light chain 9606
127 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
128 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
129 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
130 6ELJ 2 B, L fAB light chain 9606
131 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
132 4MAU 1 L C2244 light chain SEE REMARK 999 10090
133 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
134 6CBV 2 L Light Chain, Fab fragment 9606
135 4LKX 2 B Fab fragment light chain 9606
136 5JW5 2 B, L MEDI8852 Light chain 9606
137 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
138 3QWO 1 B, L motavizumab light chain 10090
139 4IOI 1 A Trastuzumab light chain 9606
140 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
141 6GHG 2 B, L Fab light chain 9606
142 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
143 5VAG 2 B Light chain of antibody m826 9606
144 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
145 5I16 1 A, L FAB LIGHT CHAIN 9606
146 5F9O 3 L CH235.09 Light chain 9606
147 1UM4 1 L Antibody 21H3 L chain 10090
148 4RBP 1 K, L Fab 2G12 light chain 9606
149 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
150 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
151 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
152 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
153 5GGQ 1 L nivolumab light chain 9606
154 6B5N 2 L CIS43 Fab Light chain 9606
155 3OAY 1 K, L Fab 2G12, light chain 9606
156 6AND 3 L Pinatuzumab Fab light chain 9606
157 5K9J 2 L 56.a.09 light chain 9606
158 5JRP 1 L marberg virus monoclonal antibody MR78 Fab light chain 9606
159 5TF1 2 L O2-CC Fab Light Chain 9606
160 3TCL 2 B, L CH04 Light Chain Fab 9606
161 4OJF 2 L Humanised 3D6 Fab Light Chain 10090
162 5F7E 2 L Fab light chain 9606
163 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
164 5FHA 2 L Antibody 114 Fab light chain 9606
165 5UMN 3 D, F Antibody C05, light chain 9606
166 4X7S 2 L Ig kappa chain C region residues 23-236 9606
167 1UM6 1 L antibody 21h3, L chain 10090
168 4X0K 2 B, L Fab fragment light chain 9606
169 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
170 5E8E 1 A IGA FAB LIGHT CHAIN 9606
171 6ELL 2 B, L fAB light chain 9606
172 2HFF 1 A, L CB2 Fab, light chain 9606
173 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
174 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
175 5GGS 2 B, D light chain 9606
176 6DG2 2 B, D 6D6 Fab light chain 10090
177 5I1L 1 A, L FAB LIGHT CHAIN 9606
178 5GGV 1 L light chain 9606
179 3L5X 1 L H2L6 LIGHT CHAIN 9606
180 5BJZ 3 H, L Synthetic antibody, Fab fragment, Light Chain 9606
181 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
182 2R8S 2 L Fab light chain 10090
183 4HKZ 1 A Trastuzumab light chain 9606
184 6DB8 3 L Fab-Light chain 32630
185 5CHN 2 B, L Antibody 5M16 Fab Light Chain 9606
186 6MEH 3 L antibody HEPC74 Light Chain 9606
187 3SO3 2 B A11 FAB light chain 9606
188 3OAU 2 L Fab 2G12, light chain 9606
189 5WEQ 1 A MR78 mutant light chain 9606
190 4WY7 2 L Fab 4E10Light chain 9606
191 4ZYK 2 B, L AM14 light chain 9606
192 6DWA 1 A, L 4497 Fab Light Chain 9606
193 6C9U 2 L Light chain of Fab 1B2 9606
194 5E94 1 A, C Antibody Fab fragment light chain 10090
195 5FB8 1 A Anti-IL-16 antibody 14.1 Fab domain Kappa Chain 10090
196 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090
197 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
198 4HIE 1 A Fab 023.102 9606
199 4LEX 1 L FAB HEAVY CHAIN 10090
200 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606
201 6MED 2 B, D, I antibody HEPC3 Light Chain 9606
202 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
203 6ME1 2 B, D VRC34.01 Fab light chain 9606
204 5ITB 2 L anti-RSV F Fab 14N4 Light chain 9606
205 5Y11 2 B MAb 4-5 light chain 9606
206 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
207 4KMT 1 L light chain O12/KAPPA Fab 9606
208 3NZH 1 L 5F6 LIGHT CHAIN 10090
209 1RHH 1 A, C Fab X5, light chain 9606
210 6CW3 2 B, D antibody light chain 9606
211 6BTJ 2 B, L Light chain of H7.5 Fab 9606
212 6BLI 2 B, E, H, K CB002.5 Fab Light Chain 9606
213 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606
214 4XTR 3 D, F Antibody Light chain 32630
215 1RZ7 1 L Fab 48d light chain 9606
216 1RZG 2 B, D Fab 412d heavy chain 9606
217 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
218 3PGF 3 L SAB Light Chain 9606
219 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606
220 6DFJ 2 L anti-Zika antibody Z021, Light Chain 9606
221 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
222 4YHL 2 L aDabi-Fab2b light chain 9606
223 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
224 6B9Y 1 A Trastuzumab Fab light chain 9606
225 5I1A 1 A, L CNTO388 LIGHT CHAIN 9606
226 2QQN 3 L Antibody light chain 9606
227 6MSY 1 L Fab 2G12, light chain 9606
228 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
229 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
230 6BAE 1 A Trastuzumab Fab light chain 10090
231 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
232 4YHM 2 L aDabi-Fab2b light chain 9606
233 6H0E 2 B, D, F, L HUMAN FAB ANTIBODY FRAGMENT OF dmCBTAU-22.1 FAB ANTIBODY FRAGMENT 9606
234 1C5B 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
235 3X3F 2 L Light chain of KMTR2 9606
236 2CMR 3 L D5 9606
237 5ZV3 3 L Light chain (kappa) of antibody CBTAU28.1 9606
238 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
239 5CZX 3 D, L 20358 Fab light chain 9606
240 6BI0 2 L, M Trastuzumab anti-HER2 Fab Light Chain 9606
241 3GRW 2 L Fab light chain 9606
242 6B3K 2 L Light chain of Fab BL3-6 10090
243 6C6Z 3 D, L Antibody CDC2-C2 light chain 9606
244 5I1D 1 A, L FAB LIGHT CHAIN 9606
245 5VKK 2 B, L Epratuzumab Fab Light Chain 10090
246 6AYZ 2 C, D Fab Light Chain 9606
247 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606
248 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
249 6CDO 2 B vFP16.02 Fab light chain 10090
250 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
251 5DRX 2 B, L CLL240 BCR light chain 9606
252 4HIX 2 L Humanized 3D6 Fab light chain 10090
253 4LKC 1 A Fab fragment of PCSK9 antibody 9606
254 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
255 4KZD 2 L BL3-6 Fab antibody, light chain 10090
256 4HCR 2 L, N PF-547659 light chain 9606
257 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
258 4HIH 1 A, C Fab 023.102 9606
259 4YHK 2 L aDabi-Fab2a light chain 9606
260 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
261 5IES 2 L VRC01cHuGL2 Fab light chain 9606
262 4UV7 3 L GC1118A 9606
263 5TKJ 2 B, E, H, K vFP1.01 chimeric mouse antibody light chain 10090
264 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606
265 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
266 3S34 1 L 1121B Fab light chain 10090
267 6AZX 2 B, D 663 antibody, light chain 9606
268 1GAF 1 L CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606
269 5E2T 1 L AT8 LIGHT CHAIN 10090
270 6B6Z 1 A, C Apo Fab Light Chain 9606
271 6EMJ 2 B, L fAb light chain 9606
272 5W1G 2 L CR1-07 Fab light chain 9606
273 6CNR 1 L Aducanumab light chain 9606
274 2RCS 1 L IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090
275 2AJ3 1 A, C, E Fab m18, Light Chain 9606
276 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630
277 3QO0 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
278 4NRX 3 B, E, L m66 Light Chain 9606
279 3O2D 1 L ibalizumab light chain 10090
280 6DB9 3 L Fab-Light-Chain 32630
281 6DDV 3 A Anti-MICA Fab fragment light chain clone 6E1 10090
282 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
283 5O14 3 D, L Fab 1A12 Light Chain 9606
284 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
285 5V7R 1 L CBTAU-7.1 Fab light chain 9606
286 6B5O 2 L CIS43 Fab Light chain 9606
287 1AJ7 1 L IMMUNOGLOBULIN 48G7 FAB (LIGHT CHAIN) VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090
288 2R0L 1 L antibody light chain 32630
289 1DN0 1 A, C IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN) FAB FRAGMENT 9606
290 5BK1 2 D, L Synthetic antibody, Fab fragment, Light Chain 9606
291 6N7U 2 B BDBV223 antibody light chain Fab 9606
292 3GIZ 1 L Fab fragment of anti-CD20 antibody Ofatumumab, light chain 9606
293 3QNZ 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
294 6N32 1 L, M Fab 2G12 light chain 9606
295 3Q1S 1 L Z13e1 Fab light chain 9606
296 6DWC 1 A, L 4497 Fab Light Chain 9606
297 3FO2 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
298 5F96 3 L LIGHT CHAIN OF ANTIBODY CH235.12 9606
299 5VR9 2 B, L CH1/Ckappa Fab light chain 9606
300 5VZ1 1 A, C Apo Antibody Fab Light Chain 9606
301 4OLU 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
302 5OD8 2 B B2 Fab fragment - Light chain 9606
303 3KR3 3 L antibody-Fab (light chain) 9606
304 5DK3 1 A, F Light Chain 9606
305 4OLX 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
306 6DZN 1 L Antibody ADI-15878, light chain 9606
307 2NY0 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
308 4YHN 2 B, L aDabi-Fab3 light chain 9606
309 5GGU 2 B, L light chain 9606
310 3QO1 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
311 4D9Q 2 D, L Anti-Factor D, light chain 9606
312 1A4J 1 A, L IMMUNOGLOBULIN, DIELS ALDER CATALYTIC ANTIBODY (LIGHT CHAIN) FAB 10090
313 5KW9 3 L IgA Light chain 9606
314 3QNY 1 A, C FAB FRAGMENT OF IMMUNOGLOBULIN A1 LIGHT CHAIN 9606
315 1YYM 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
316 5W2B 2 L Fab Light Chain 9606
317 5DRW 2 B CLL183 BCR antibody light chain 9606
318 1FL5 1 A, L ANTIBODY GERMLINE PRECURSOR TO ANTIBODY 28B4 LIGHT CHAIN (CHAINS L AND A) 10090
319 2O5Z 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
320 4OM0 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
321 5MVZ 2 B, L Fab 4AB007 L-chain 9606
322 3AAZ 2 B, L Humanized recombinant Fab fragment of a murine; antibody 9606
323 4QXG 2 L Fab, light chain, IgG1 Fab, light chain 9606
324 3O2V 1 L Chimeric antibody Fab 1E9, light chain 10090
325 2I5Y 2 L, Q Antibody 17B Light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
326 2FX9 1 L, M Fab 4E10 Light Chain 9606
327 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
328 6AXL 1 B, C Fab317 light chains 9606
329 1BZ7 1 A PROTEIN (ANTIBODY R24 (LIGHT CHAIN)) FAB 10090
330 1TZG 1 L, M Fab 4E10 light chain 9606
331 3W9D 2 B, D Antibody Fab light chain 9606
332 6CXG 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
333 6CO3 1 L Fab light chain 9606
334 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
335 3BN9 2 C, E E2 Fab Light Chain 9606
336 6EYN 1 A, C, L 8D6 Fab light chain 8D6 Fab light chain 9606
337 4HWE 2 L Fab light chain light chain 9606
338 6DF0 1 L 4G10-4D5 Antibody Light chain 32630
339 6DF1 1 L Anti-phosphotyrosine antibody 4G10-4D5 heavy chain 9606
340 5TZ2 2 L C47B222 Fab Light Chain 9606
341 6MLK 2 L Light chain of Fab 3A6 9606
342 6CDM 2 B, E vFP7.04 light chain 10090
343 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
344 4OGX 3 L DX-2930 LIGHT CHAIN 9606
345 3W9E 3 B Antibody Fab light chain 9606
346 5TFS 2 L 02-K Fab Light chain 9606
347 3UTZ 1 A, D, E Metalloproteinase, light chain 10090
348 5E2U 1 L AT8 LIGHT CHAIN 10090
349 4KZE 2 L BL3-6 Fab antibody, light chain 10090
350 5WT9 2 L Light Chain of Nivolumab 9606
351 4HIJ 1 A, C Fab 023.102 light chain 9606
352 6MU3 1 K, L Fab 2G12, light chain 9606
353 3FO1 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
354 4XVU 3 D, F, J, L Antibody light chain 32630
355 5B71 1 A, C SKY59 Fab light chain 9606
356 6BF4 3 C, L VRC-PG05 Fab light chain 9606
357 3QCT 2 L LT3015 antibody Fab fragment, light chain 9606
358 3EYF 1 A, C 8f9 Fab 9606
359 3NAB 1 L Fab15 Mut6 light chain 9606
360 4Q9Q 2 L Fab BL3-6, LIGHT CHAIN 10090
361 5I1C 1 L FAB LIGHT CHAIN 9606
362 5VZY 2 L Crenezumab Fab light chain,Immunoblobulin light chain 9606
363 5WNA 2 D, L mAb 3D3 Fab light chain 9606
364 1RZ8 1 A, C Fab 17b light chain 9606
365 4WV1 3 A, D Fab light chain 9606
366 6ANP 1 A, L CAT192 Fab Light chain 9606
367 5EII 2 B, L Fab Light Chain 9606
368 5KZP 2 I, J, K, L HCV1-C1 Antibody Fab Light Chain 9606
369 4OLY 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
370 4FNL 2 L, M Antibody C05, Light Chain 9606
371 4UB0 2 L IgG1, light chain 9606
372 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
373 1BJ1 1 J, L Fab fragment, light chain HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
374 5I1H 1 L FAB LIGHT CHAIN 9606
375 6IUV 2 D, L 3C11 Light Chain 9606
376 2FX8 1 L, M, N, O Fab 4E10 Light Chain 9606
377 1NGY 1 A Mature Metal Chelatase Catalytic Antibody, Light chain Fab fragment 10090
378 6BFT 1 B, L Avastin Light Chain Fab fragment mutant 9606
379 6DFI 2 L anti-Zika antibody Z021, Light Chain 9606
380 5I1J 1 L FAB LIGHT CHAIN 9606
381 3IDX 3 L Fab b13 light chain 9606
382 5CIP 2 B, L FAB 4E10 LIGHT CHAIN 9606
383 6AO0 1 L CAT192 Fab Light chain 9606
384 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
385 4K94 1 L Fab19 heavy chain 9606
386 5K9Q 4 I, K, L, T, V, Y 16.a.26 Light chain 9606
387 6B5L 2 L CIS43 Fab Light Chain 9606
388 1I7Z 1 A, C CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION THE CHIMERA CONSISTS OF RESIDUES 1-108 OF MOUSE PORTION AND 109-214 OF HUMAN PORTION OF IG KAPPA CHAIN. 10090
389 4JPK 2 L Putative VRC01 germline precursor Fab light chain 9606
390 5XAJ 2 B, L FabHM14c10 light chain 9606
391 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
392 5VEB 2 B, L anti-CDH6 Fab light chain 9606
393 5VZX 2 I, L Crenezumab Fab light chain 9606
394 6DWI 1 A, C, E, G, I, K, M, O 4462 Fab Light Chain 9606
395 3FCT 1 A, C PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY) CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606
396 3X3G 2 L Light chain of KMTR2 9606
397 5WAW 1 L fAb Light Chain 9606
398 5E08 2 L Fab Light Chain 9606
399 6AZ2 3 E, F Fab Light Chain 9606
400 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN 10090
401 5IBT 2 L UCA Light Chain 9606
402 6CA6 1 A, L PCT64_35S light chain 9606
403 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
404 5JQ6 3 L Tefibazumab FAB FRAGMENT LIGHT CHAIN 10090
405 1A4K 1 A, L ANTIBODY FAB FAB 10090
406 6DF2 1 A, L Anti-phosphotyrosine antibody c310-4D5 heavy chain 32630
407 5MO9 2 L AB20 Fab light chain 10090
408 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
409 5XRQ 2 B, L Fab H3v-47 light chain 9606
410 6AL4 1 A, C, E B43 LIGHT CHAIN 9606
411 2I60 2 L, Q ANTIBODY 17B LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
412 4NGH 1 L FAB LIGHT CHAIN 9606
413 5WB9 3 L N60P23 Fab light chain 9606
414 4EDW 2 L tanezumab Fab light chain 9606
415 1UCB 1 L CHIMERIC HUMAN/MOUSE IGG FAB FRAGMENT BR96 MOUSE VH AND VL DOMAINS, HUMAN CL KAPPA AND CH1 IGG1 DOMAINS 9606
416 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
417 2NY5 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
418 4NM4 1 L, M Antibody CR8043, Light Chain 9606
419 4LST 3 L LIGHT CHAIN OF ANTIBODY VRC01 9606
420 3U7Y 3 L NIH45-46 light chain, Ig kappa chain C region 9606
421 4D9R 2 D, L Fab light chain 9606
422 3U7W 2 L Light chain, Ig kappa chain C region 9606
423 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
424 4G7V 2 L fragment antibody light chain 9606
425 5W06 2 L M1587 FAB LIGHT CHAIN 10090
426 4HFW 1 A, L 6-26 Fab Light chain 9606
427 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
428 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
429 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
430 4S1Q 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
431 5JO4 2 B D80 Fab Light Chain 9606
432 5JO4 4 D G6 Fab Light Chain 9606
433 4KQ4 1 L CNTO7357 light chain Fab (mouse variable domain, human constant domain) 10090
434 3INU 2 L, N KZ52 antibody fragment light chain 9606
435 5EU7 3 C, D FAB light chain 9606
436 4OLV 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
437 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606
438 2EH7 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090
439 6CDP 2 B vFP20.01 Fab light chain 10090
440 5X8M 3 C durvalumab light chain 9606
441 6AMJ 1 A, L CAT192 Fab light chain 9606
442 1RZJ 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606
443 4HII 1 A, C Fab 023.102 light chain 9606
444 2EH8 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090
445 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606
446 4DN3 1 L CNTO888 LIGHT CHAIN 9606
447 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606
448 4LSS 3 L LIGHT CHAIN OF ANTIBODY VRC01 with N72T mutation 9606
449 5WNB 2 L, M mAb 3D3 Fab light chain 9606
450 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606
451 3EYV 1 A, L hu3S193 Fab, light chain 10090
452 1GC1 3 L ANTIBODY 17B MONOCLONAL ANTIBODY 17B BINDS TO A CD4-INDUCED SITE ON GP120 ANTIGEN-BINDING FRAGMENT, FAB 9606
453 1HKL 1 L 48G7 FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606
454 3PP3 2 K, L GA101 Fab light chain 10090
455 5IJK 3 C, D 1E03 Fab fragment light chain 9606
456 3BDY 2 L Fab Fragment -Light Chain 9606
457 5I8E 2 B, D VRC34.01 Fab light chain 9606
458 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606
459 1G9M 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
460 5UIX 2 L DH576 Fab light chain 9606
461 3K2U 4 L Antibody, Fab fragment, Light Chain 9606
462 6MFT 2 B, L Light chain glVRC01 9606
463 4HWB 3 L Fab light chain 9606
464 5VSH 2 B, D, F, L CH1/Clambda Fab light chain 9606
465 3O2W 1 L Chimeric antibody Fab 1E9, light chain 10090
466 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090
467 2HFG 1 L CB3s Fab light chain (kappa) 9606
468 3GKW 2 L Light chain of the antibody Nimotuzumab 9606
469 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606
470 5ZIA 2 B, E, I, L, M, P Light chain (kappa) of CBTAU-24.1 antibody 9606
471 4JQI 3 L Fab30 light chain 10090
472 6B0H 3 A, C 1262 antibody, light chain 9606
473 3SKJ 1 L, M Antibody, light chain 9606
474 3U30 2 B, E Light chain Fab 9606
475 6B0A 2 L 1269 antibody, light chain 9606
476 3QCV 2 L, M LT3015 antibody Fab fragment, light chain 9606
477 3U0T 1 A, C ponezumab LC Fab 9606
478 5HYS 2 B, D, F, L Uncharacterized protein 9606
479 3FO0 1 L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
480 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606
481 5I15 1 L FAB LIGHT CHAIN 9606
482 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606
483 5I1E 1 L FAB LIGHT CHAIN 9606
484 2NYY 2 C CR1 monoclonal antibody light chain 9606
485 2GCY 1 A huC25 fab fragment light chain 10090
486 4JLR 2 B, L Motavizumab Fab light chain 9606
487 2QQK 3 L Antibody Light Chain 9606
488 4J1U 1 A, C, E antibody 93F3 Light chain 10090
489 5N4G 2 L LIGHT CHAIN 9606
490 3NGB 3 C, F, K, L Antigen binding fragment of light chain: Antibody VRC01 9606
491 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606
492 5SX5 1 K, L Panitumumab Fab Light Chain 9606
493 5JQD 1 A, B D80 Fab Fragment Light Chain 9606
494 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606
495 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090
496 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606
497 4KXZ 3 I, L, M, P GC1008 Light Chain 9606
498 5BK2 3 D, L sAB Light Chain 9606
499 1TZH 2 A, L Fab YADS1 Light Chain 10090
500 5O1R 3 L, M Uncharacterized protein 9606
501 6CMI 2 C m102.3 light chain 9606
502 4XML 1 L Light chain of HIV-1 gp120 V3-specific human monoclonal antibody 2424 9606
503 4JZJ 3 B, L Fab Light Chain 10090
504 5BMF 2 L Fab fragment light chain 9606
505 5BO1 3 L, M Fab light chain 9606
506 6FOE 2 B, L Fab BaxB01 light chain engineered Fab light chain binds oxidized macrophage migration inhibitory factor (MIF) 9606
507 4M6O 1 L CNTO7309 light chain 9606
508 3QEH 2 B, D, F, H Fab fragment of human anti-HIV-1 Env antibody N12-i15,light chain Fab light chain 9606
509 4OLW 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
510 5LSP 3 L, T 107_A07 Fab light chain 9606
511 4DVR 2 L Fab 48d Light chain 9606
512 3EYQ 1 C M2J5 Fab 9606
513 5BK3 1 B, D, F, L 580 Antibody, light chain 9606
514 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630
515 2O5Y 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
516 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606
517 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606
518 4XXD 1 A, D Fab Light Chain 9606
519 5F9W 3 C, L Light chain of CH235-lineage antibody CH235 9606
520 6BGT 2 A Herceptin light chain mutant 9606
521 6H06 2 B, D, F, L HUMAN FAB ANTIBODY FRAGMENT OF HCBTAU-22.1 FAB ANTIBODY FRAGMENT 9606
522 1CLY 1 L IGG FAB (HUMAN IGG1, KAPPA) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER CHIMERIC FRAGMENT (BR96) 9606
523 4XBG 1 B, D, F, I, K, L 4E10 Fab light chain 9606
524 1YYL 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
525 2NY6 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
526 5FUZ 2 L 645 FAB, LIGHT CHAIN 9606
527 3DVG 1 A Human IgG1 fab fragment light chain 9606
528 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606
529 2AGJ 1 L Yvo Fab, Light Chain 9606
530 4JKP 3 L Light chain of antibody 45-46M2 9606
531 3EYO 1 A, C 8f9 Fab 9606
532 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606
533 5BZD 1 A, C 5G8 HIV Antibody light chain 9606
534 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606
535 3B2U 1 D, G, K, L, O, R, U, X IMC-11F8 Fab Light chain 9606
536 4DN4 1 L CNTO888 LIGHT CHAIN 9606
537 5TRP 2 L DH272 Fab light chain 9606
538 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606
539 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090
540 6MHR 2 B, E Urelumab Fab kappa chain 9606
541 2FJG 2 A, L Fab light chain 9606
542 4DKF 3 L, M FAb2 Light Chain 9606
543 5TLK 1 A, E M2177 LIGHT CHAIN 10090
544 5TLK 3 C, G H2191 LIGHT CHAIN 10090
545 1UWE 2 L, U, X ANTIBODY 14D9 FAB LIGHT CHAIN, RESIDUES 1-212 10090
546 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606
547 6MEJ 5 L antibody HEPC3 Light Chain 9606
548 1IT9 1 L HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN FAB FRAGMENT 10090
549 3EFD 1 L FabL 10090
550 4LF3 1 A, D Fab heavy chain 10090
551 5K59 4 F, L Fab light chain 9606
552 6MUB 1 K, L Fab 2G12, light chain 9606
553 6BFQ 2 B, D, F, L Fab Light Chain 9606
554 5WI9 2 E, L 39F7 Fab light chain 9606
555 1UWG 2 L, X ANTIBODY 14D9 CATALYTIC ANTIBODY 19C9 FAB LIGHT CHAIN, RESIDUES 1-213 10090
556 6BKC 2 L Fab AR3B light chain 9606
557 5KN5 2 B, E Epiregulin Antibody LY3016859 Fab Light Chain 9606
558 4XCN 1 B, D, F, I, K, L 4E10 Fab light chain 9606
559 5F3H 2 B, D, F, H humanized RK35 antibody light chain 10090
560 4LEO 2 B RG7116 Fab light chain 10090
561 4G7Y 2 L Fragment antibody light chain 9606
562 6B3S 3 D, G, K, L Necitumumab Fab Light chain 9606
563 4PY8 4 J antibody 3.1 light chain Fab 9606
564 3SDY 4 L Antibody CR8020, Light Chain 9606
565 3DVN 1 A, L Human IgG1 fab fragment light chain 9606
566 3IXT 1 B, L Motavizumab Fab light chain 10090
567 6FAX 1 L Lob 7.4 light chain 9606
568 4NP4 3 L, M bezlotoxumab light chain 9606
569 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598
570 4XCE 1 B, D, L 4E10 Fab light chain 9606
571 5I1I 1 L FAB LIGHT CHAIN 9606
572 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606
573 4ERS 1 L Fab light chain 9606
574 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606
575 4MWF 2 B, L Fab AR3C light chain 9606
576 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
577 3SQO 3 L J16 Light chain 9606
578 4K3J 4 L Onartuzumab Fab light chain 10090
579 6CYF 2 C, E, L, T IgG1 antibody, kappa light chain 9606
580 4PS4 1 L M1295 LIGHT CHAIN 9606
581 5GGT 3 L IGK@ protein 9606
582 6MNF 1 K, L Fab 2G12, light chain 9606
583 3HI1 2 A, L F105 Light Chain 9606
584 4PY7 2 B, J antibody 3.1 light chain Fab 9606
585 6AL5 2 L B43 LIGHT CHAIN 9606
586 4K8R 3 C Fab1, light chain 9606
587 1RZK 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606
588 5VOB 7 L Fab 8I21 light chain 9606
589 6CMG 2 B m102.3 light chain 9606
590 1G9N 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
591 6ML8 4 L C05 antibody Fab light chain 9606
592 1TZI 1 A Fab YADS2 Light Chain 10090
593 1QLR 1 A, C IGM KAPPA CHAIN V-III (KAU COLD AGGLUTININ) FAB FRAGMENT 9606
594 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090
595 4X7T 2 B, L Omalizumab-Fab Light chain 9606
596 4YK4 1 B, Y 641 I-9 VLCL antibody 9606
597 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606
598 1MHP 3 L, Y FAB FRAGMENT, light chain 10090
599 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544
600 5XMH 2 C, L YES8c light chain 9606
601 1FL6 1 A, L ANTIBODY GERMLINE PRECURSOR TO 28B4 LIGHT CHAIN (CHAINS L AND A) 10090
602 5U3J 2 L DH511.1 Light Chain Fragment of antigen binding 9606
603 6MEI 3 L antibody HEPC3 Light Chain 9606
604 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606
605 5I1G 1 L FAB LIGHT CHAIN 9606
606 2QQL 3 L Antibody Light Chain 9606
607 4XCC 1 L 4E10 Fab light chain 9606
608 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606
609 5SX4 1 I, L Panitumumab Fab Light Chain 9606
610 3WD5 2 L Adalimumab Light Chain 9606
611 5Y2L 4 J a group 2 HA binding antibody AF4H1K1 Fab light chain 9606
612 4NHC 1 L FAB LIGHT CHAIN 9606
613 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606
614 5GZO 3 D, L Antibody light chain 9606
615 2HH0 1 L Light Chain, P-Clone Fab, Chimera 2-109 (mouse), 110-271 (human) 10090
616 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
617 5GMQ 3 C MCA1 light chain 9606
618 6CA9 1 A, C PCT64_LMCA Fab light chain 9606
619 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606
620 4HFU 4 L Fab 8M2 light chain 9606
621 5TRU 1 L, l Ipilimumab Fab light chain 9606
622 4FP8 3 L, M, N, O Antibody C05, light chain 9606
623 6BKB 3 L Fab AR3A light chain 9606
624 6I8S 3 I, J, K, L LIGHT CHAIN OF FAB FRAGMENT FROM AN PAI-1 ANTIBODY FAB FRAGMENT 562
625 4YPG 1 A, L Sifalimumab light chain 9606
626 6CW2 4 B antibody light chain 9606
627 3BE1 3 L Fab Fragment-Light Chain 9606
628 2FJH 2 A, L Fab fragment light chain 9606
629 5XEZ 3 D, L Antibody, mAb1, light chain 9606
630 4K9E 1 L light chain 10090
631 6MEF 2 L antibody AR3C Light Chain 9606
632 3P0V 1 L, M Fab DL11 light chain 9606
633 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606
634 4FZ8 2 L FAB light chain of human ANTI-HIV-1 ENV ANTIBODY C11 9606
635 5VIG 2 B, L Fab light chain 9606
636 4UTA 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 LIGHT CHAIN FAB FRAGMENT 9606
637 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606
638 6I04 3 D, L Fab light chain 9606
639 4KVN 3 L Human IgG Light Chain 9606
640 4KUC 2 D, E mAb6c2 fab-Heavy chain 10090
641 5VYF 1 A, L Antibody light chain 10090
642 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606
643 5WUX 2 B, D, L light 9606
644 3OB0 1 K, L Fab 2G12, light chain Fab 9606
645 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606
646 5VQM 2 C, L PA41 FAB LIGHT CHAIN 9606
647 6GK7 1 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-27.1(S31Y,T100I) FAB ANTIBODY FRAGMENT 9606
648 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606
649 5DUM 2 L 65C6 Light Chain 9606
650 4I18 1 B, L antibody light chain Fab 10090
651 4Q9R 2 L Fab BL3-6, LIGHT CHAIN 10090
652 3KYM 1 A, C, E, G, I, K, M, O Light Chain Li33 IgG2 9606
653 3IDY 3 C, L Fab b13 light chain 9606
654 4OQT 2 L Light Chain of Li81 Fab, kappa 3 9606
655 3IVK 1 B, L Fab light chain man 10090
656 3KYK 2 L Light Chain Li33 IgG1 9606
657 5TGB 2 B, L 02-CB Fab Light Chain 9606
658 5I19 1 L FAB LIGHT CHAIN 9606
659 5TH9 1 L, M, N GS-5745 Fab light chain 9986
660 5JOF 2 B, D, F, L VRC03 gLV light chain 9606
661 4IRZ 2 L Fab Natalizumab light chain 9606
662 5X8L 2 K, L, M, N, O atezolizumab light chain 9606
663 5UDC 2 C, G, L MEDI8897 Fab Light Chain 9606
664 6GK8 2 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-28.1(S32R;E35K) FAB ANTIBODY FRAGMENT 9606
665 5FEC 2 B, L germline 3BNC60 light chain 9606
666 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606
667 2R56 2 L, M IgE Fab Fragment, light chain 9606
668 1ZA6 1 A, C, E, G IGG Light chain 9606
669 4YWG 1 L, M Light chain of anti-HIV-1 gp120 V1V2 antibody 830A 9606
670 6FGB 3 L 1519.g57- Light chain 9606
671 4ZS6 1 D, L fab Light Chain 9606
672 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606
673 6APB 3 L ADI-14359 Fab Light Chain 9606
674 1U6A 1 L F105 LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
675 4XBP 1 B, D, F, L 4E10 FAB LIGHT CHAIN 9606
676 5K9K 2 B, L 56.a.09 Light chain 9606
677 1NGW 1 A, L Mature Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
678 5BZW 1 A 2B3 HIV Antibody light chain EIVLTQSPGTLSLSPGERATLSCRASQSVSAKNLAWYQQKPGQTPRLLMYGVSLRNTGVP DRFSGSGSGTDFTLTISRLEPEDSAVYFCQQYGTSPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC 9606
679 5W4L 6 C, E Antibody N12-i3 light chain 9606
680 5CD3 2 B, D, F, H DRVIA7 Light Chain 9606
681 6D01 2 B, D, F, H 1210 Antibody, Light chain 9606
682 5CZV 3 L Fab 20350 light chain 9606
683 5XF1 3 D, L Antibody mAb1 Light chain 9606
684 4P59 3 L MOR09825 Fab fragment light chain 9606
685 5XXY 2 L light chain of atezolizumab fab 9606
686 5CJO 3 L FAB light chain 10090
687 4LMQ 3 I, L Stromal cell-derived factor 1 9606
688 3N85 2 L Fab37 Light Chain 9606
689 6AMM 1 L CAT192 Fab Light chain 9606
690 3G6J 3 E, G Fab light chain 9606
691 5GJT 3 L light chain of human neutralizing antibody 3E1 light chain of neutralizing antibody 3E1 9606
692 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606
693 6B9J 3 B, L Fab vv138 Light chain 9606
694 5O4G 2 A MF3958 FAB light chain 9606
695 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606
696 4DKE 3 L, M FAb1.1 Light Chain 9606
697 5A3I 4 D, H ANTI-HAEMAGGLUTININ HA1 FAB LIGHT CHAIN 9606
698 5I17 1 A, L FAB LIGHT CHAIN 9606
699 5VIC 2 L Fab light chain 9606
700 6MEK 3 D, L HEPC3 Light Chain 9606
701 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606
702 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606
703 4R8W 4 L Light chain of neutralizing antibody CT149 9606
704 5TPN 3 L hRSV0 light chain 9606
705 5GJS 3 L light chain of human neutralizing antibody 3E1 9606
706 1I9R 3 L, M, Y IMMUNOGLOBULIN L 9606
707 4NRY 1 B, L m66 Heavy Chain 9606
708 6N2X 1 K, L Fab 2G12 light chain 9606
709 4XMK 1 L, M, N Light chain of HIV-1 gp120 V3-specific human monoclonal antibody 2424 9606
710 3S37 1 L 1121B Fab light chain 10090
711 5TZT 1 B, L Light Chain of Fab C47B161 9606
712 5XHF 1 A, C polypeptide (L chain) 10090
713 5VL7 4 L Fab33 light chain 9606
714 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090
715 5JXE 2 C, F Pembrolizumab Fab light chain 9606
716 5KZC 3 D, G, L VRC01 Fab light chain 9606
717 5W42 4 L Fab H3v-47 light chain 9606
718 4JM2 3 C 17b Light chain Fab 9606
719 6DEZ 1 A, L Anti-phosphotyrosine antibody PY20-4D5 light chain 32630
720 1S78 2 C, E Pertuzumab Fab light chain 10090
721 5BK0 1 A, C 663 Antibody, light chain 9606
722 4UV4 2 L FPRO0165 FAB LIGHT CHAIN 9606
723 4NYL 1 B, D, F, L Adalimumab Light Chain 9606
724 5D1Z 1 A, H Y10 Light Chain 9606
725 5D1Z 3 C, E D4-10 Light Chain 9606
726 5GGR 2 B, L light chain 9606
727 5IBL 4 D, L 6639 Light Chain 9606
728 4XHJ 3 C, G Fab-RC light chain 9606
729 4JDT 3 L Fab light chain NIH45-46 LIGHT CHAIN 9606
730 5O4O 1 A MF3178 FAB light chain 9606
731 5HJ3 4 B, F, J, N KZ52 Antibody Fragment 9606
732 4N90 3 E, G, I Fab light chain 9606
733 5BK5 2 A, C, E, G 663 germline antibody, light chain 9606
734 5VGJ 3 L VRC38.01 Fab Light Chain 9606
735 4UBD 4 D, H, L, P, T, X monoclonal antibody L chain 9606
736 6B0E 1 A 1260 antibody, light chain 9606
737 5D1Q 1 A D2-06 Light Chain 9606
738 5D1Q 4 D P5 Light Chain 9606
739 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606
740 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598
741 3EO1 1 A, D, G, J GC-1008 Fab Light Chain 10090
742 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
743 5XHV 3 L, Q S40 light chain 9606
744 5UWE 2 L HUMAN ANTI-HIV ANTIBODY N12-I2 Fab LIGHT CHAIN 9606
745 4IOF 3 D, F Fab-bound IDE, light chain 10090
746 5FUO 3 L FAB LIGHT CHAIN 9606
747 5FEH 1 A, C, E PCT64_26 Fab light chain 9606
748 4JHW 2 L D25 light chain 9606
749 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606
750 6CXL 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
751 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606
752 4M1C 3 D, F Fab-bound IDE, light chain 9606
753 5UQY 3 C, G, K, O MR78 Fab light chain 9606
754 6D0U 3 D, F, I, L Antibody C05, light chain 9606
755 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606
756 3ULV 2 L Fab15 light chain 9606
757 5UG0 3 C 2897 light chain 9606
758 4M7L 2 L 10H10 light chain SEE REMARK 999 10090
759 4S1R 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
760 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606
761 6N7J 2 B, L BDBV223 antibody light chain Fab 9606
762 5UOE 3 L, N, Q, T, W FAB light chain 9606
763 5VL3 3 B, D, F, L Epratuzumab Fab Light Chain 10090
764 5D1X 1 A D4-30 Light Chain 9606
765 5D1X 4 D P5 Light Chain 9606
766 5JW3 4 L MEDI8852 light chain 9606
767 5WKO 2 B, D, F, H, J, L Antibody 27F3 light chain 9606
768 5UMI 2 B, L PA50 Fab Light chain 9606
769 6BKD 3 L Fab AR3D light chain 9606
770 6D11 2 B, D 1450 Antibody, Light chain 9606
771 6APD 3 E, G, I AM22 Fab Light Chain,Uncharacterized protein 9606
772 2NZ9 2 C, E AR2 monoclonal antibody light chain 9606
773 3S36 1 L 1121B light chain 10090
774 5CWS 1 A, G sAB-158 Fab Light Chain 9606
775 5I5K 3 L, Y Eculizumab light chain (variable domain) 9606
776 4S1S 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
777 2R0K 2 L antibody light chain of Fab58 9606
778 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606
779 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606
780 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606
781 4G80 3 B, D, F, H fragment antibody light chain 9606
782 3JWO 3 L FAB 48D LIGHT CHAIN 9606
783 5CD5 3 D DRVIA7 Fab Light Chain 9606
784 5Y2M 4 J, L a group 2 HA binding antibody AF4H1K1 Fab light chain 9606
785 3P11 2 L Fab DL11 light chain 9606
786 6EYO 3 L, M 8D6 Fab light chain 8D6 Fab light chain 9606
787 3F12 1 A, C M2J1 Fab 9606
788 3B2V 1 L IMC-11F8 FAB Light chain 9606
789 5IGX 3 L germline NIH45-46 light chain 9606
790 3ULU 2 L Fab15 light chain 9606
791 5KAQ 3 G, L, R ANTIBODY 31.A.83 FAB LIGHT CHAIN 9606
792 6ATT 3 L Antibody 39S Fab light chain Antibody, light chain 9606
793 5W1K 1 A, F, K, S CR1-28 Fab light chain 9606
794 5W1K 3 C, H, M, N CR1-10 Fab light chain 9606
795 4XI5 3 C Fab-94 light chain 9606
796 5WOB 4 J, L, N, P, R, T, V, X IDE-bound Fab light chain 60742
797 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606
798 6EAY 1 L CA45 light chain 9541
799 5G64 3 L, M FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-218 9606
800 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606
801 5W1M 1 A, C, E, G CR1-07 Fab light chain 9606
802 4XCY 1 B, D, F, I, K, L 4E10 Fab light chain 9606
803 5K9O 2 B, L 31.b.09 Light Fv 9606
804 5TLJ 1 A, E M2177 LIGHT CHAIN 10090
805 5TLJ 3 C, G M2191 LIGHT CHAIN 10090
806 5JW4 4 N, P, T, V, X MEDI8852 light chain 9606
807 5JW4 6 R MEDI8852 light chain 9606
808 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606
809 5UDD 3 P, Q, R, S, T, U MEDI8897 Fab Light Chain 9606
810 5VOC 7 L Fab 8I21 light chain 9606
811 5J3D 2 B, D, L 14N4 light chain 9606
812 2B4C 3 L anti-HIV-1 gp120 immunoglobulin X5 light chain 9606
813 5ESZ 2 B, L CH04 Light Chain 9606
814 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606
815 3EFF 1 A, C FAB 10090
816 3PJS 1 A, C FAB light chain 10090
817 6MAM 2 B, D, F ADI-15946 Fab Light Chain 9606
818 5O7P 2 A MF3178 FAB light chain 9606
819 4ZYP 3 L, M, O Motavizumab antibody light chain 10090
820 4ZYP 5 E, G, I AM14 antibody light chain 9606
821 6B3M 4 D, J, N, P, U, W 70-1F02 Fab Light Chain 9606
822 5DWU 4 L Fab - Light Chain 9606
823 5V2A 3 L Light chain (kappa) of H7.167 antibody Fab 9606
824 6EA7 4 L, N, R ADI-15878 Fab Light Chain 9606
825 5I8H 5 F, H VRC34.01 Fab light chain 9606
826 4RQS 2 C 17b Fab Light Chain 9606
827 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606
828 4R4H 3 L Antibody 2.2c, Light chain 9606
829 6EA5 4 L, N, R ADI-15878 Fab Light Chain 9606
830 5VOD 7 L Fab 9I6 light chain 9606
831 5FHC 5 L Antibody 114 Fab light chain 9606
832 4XMN 6 L Antibody 87 light chain 32630
833 4XMM 8 L Antibody 57 light chain 9606
834 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606
835 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606
836 6MZJ 2 C, L VRC01GL light chain germline VK3-11 with the mature CDRL3 of VRC01 9606
837 6MYY 2 C, F, L VRC01GL light chain germline VK3-11 with the mature CDR L3 of VRC01 9606
838 6MLM 4 G, I, L Light chain Fv of H7.5 Fab 9606
839 6MJZ 3 L PIA174 Fab Light chain 9606
840 6HJP 4 H, J, L Light chain of FISW84 Fab Fragment 9606
841 6HJQ 4 H, J, L Light chain of FISW84 Fab 9606
842 6E5P 1 1, 4, K, L, Q, T 2G12 Light chain 9606
843 6E1K 2 C, E cat06 light chain 9606
844 6DJP 6 F 68 light chain Fab 10090
845 6CUF 2 4, L, l vFP1.01 Light chain 10090
846 6CMO 5 L Fab light chain 32630
847 6CM3 4 J, L, N 17b Fab light chain 9606
848 6CDE 2 4, L, l vFP20.01 Light chain 9606
849 6CDI 8 4, L, l vFP16.02 Light Chain 9606
850 6BF7 3 D, F Fab H11-E light chain 10090
851 6BF9 3 D, F Fab H11-E light chain 10090
852 6B7Z 3 D, F FAB H11 light chain 10090
853 6B70 3 D, F FAB H11-E light chain 10090
854 5VN3 1 L, N, O 17b Fab light chain 9606
855 5GZR 4 L, N Z23 Fab light chain 9606
856 5THR 4 J, K, L 17b Fab VL domain 9606
857 5A8H 3 C, I, O FAB OF BROADLY NEUTRALIZING ANTIBODY 17B 9606
858 5A7X 3 C, G, K FAB OF BROADLY NEUTRALIZING ANTIBODY 17B 9606
859 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606
860 3CM9 3 L, M, N, O Ig alpha-2 chain C region 9606
861 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606
862 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606
863 2ESG 1 L, M Immunoglobulin A1 light chain 9606
864 1R70 1 A, C Human IgA2(m1) Light Chain 9606
865 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606